Fatal myelodysplastic syndrome developing during therapy with imatinib mesylate and characterised by the emergence of complex Philadelphia negative clones

被引：22

作者：

Chee, YL

Vickers, MA

Stevenson, D

Holyoake, TL

Culligan, J

机构：

[1] Aberdeen Royal Infirm, Dept Haematol, ANCHOR Unit, Aberdeen AB25 2ZN, Scotland

[2] Aberdeen Royal Infirm, Dept Cytogenet, Aberdeen AB25 2ZN, Scotland

[3] Univ Glasgow, Royal Infirm, Div Canc Sci & Mol Pathol, Glasgow G31 2ER, Lanark, Scotland

来源：

LEUKEMIA | 2003年 / 17卷 / 03期

关键词：

D O I：

10.1038/sj.leu.2402842

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：634 / 635

页数：2

共 4 条

[1] Clonal Ph-negative hematopoiesis in CML after therapy with imatinib mesylate is frequently characterized by trisomy 8 [J].

Andersen, MK ;

Pedersen-Bjorgaard, J ;

Kjeldsen, L ;

Dufva, IH ;

Brondum-Nielsen, K .

LEUKEMIA, 2002, 16 (07) :1390-1393

[2] Hematopathologic and cytogenetic findings in imatinib mesylate-treated chronic myelogenous leukemia patients: 14 months' experience [J].

Braziel, RM ;

Launder, TM ;

Druker, BJ ;

Olson, SB ;

Magenis, RE ;

Mauro, MJ ;

Sawyers, CL ;

Paquette, RL ;

O'Dwyer, ME .

BLOOD, 2002, 100 (02) :435-441

[3] Malignancies after hematopoietic stem cell transplantation:: Many questions, some answers [J].

Deeg, HJ ;

Socié, G .

BLOOD, 1998, 91 (06) :1833-1844

[4] Sustained, clonal karyotype abnormalities in the Philadelphia chromosome negative cells of CML patients successfully treated with imatinib [J].

Meeus, P ;

Demuynck, H ;

Martiat, P ;

Michaux, L ;

Wouters, E ;

Hagemeijer, A .

LEUKEMIA, 2003, 17 (02) :465-467

← 1 →